Bleakley Financial Group LLC Sells 736 Shares of Privia Health Group, Inc. $PRVA

Bleakley Financial Group LLC reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVAFree Report) by 4.3% in the second quarter, Holdings Channel.com reports. The institutional investor owned 16,560 shares of the company’s stock after selling 736 shares during the period. Bleakley Financial Group LLC’s holdings in Privia Health Group were worth $381,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Privia Health Group by 180.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock worth $59,112,000 after buying an additional 1,693,870 shares in the last quarter. Van Berkom & Associates Inc. bought a new position in Privia Health Group in the first quarter worth about $45,207,000. Northern Trust Corp raised its stake in Privia Health Group by 2.2% in the first quarter. Northern Trust Corp now owns 1,423,865 shares of the company’s stock worth $31,966,000 after buying an additional 31,224 shares in the last quarter. Nuveen LLC bought a new position in Privia Health Group in the first quarter worth about $26,899,000. Finally, Charles Schwab Investment Management Inc. raised its stake in Privia Health Group by 5.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,192,362 shares of the company’s stock worth $26,769,000 after buying an additional 58,489 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on PRVA shares. Evercore ISI decreased their price target on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th. Piper Sandler decreased their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a research note on Monday, August 11th. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Privia Health Group in a research note on Saturday. Finally, JMP Securities raised their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research note on Friday, August 29th. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $28.91.

Check Out Our Latest Report on PRVA

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $25.99 on Monday. Privia Health Group, Inc. has a fifty-two week low of $17.45 and a fifty-two week high of $26.49. The company has a 50 day simple moving average of $23.52 and a two-hundred day simple moving average of $22.68. The company has a market capitalization of $3.19 billion, a price-to-earnings ratio of 236.29, a P/E/G ratio of 3.55 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVAGet Free Report) last announced its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. On average, analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

About Privia Health Group

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVAFree Report).

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.